Fig. 4.
Fig. 4. Overall survival (OS) according to the presence or absence of BCL-6 mutation. / OS rates at 68 months 58% (BCL-6 mutated, solid line) versus 44% (BCL-6 nonmutated, dotted line).

Overall survival (OS) according to the presence or absence of BCL-6 mutation.

OS rates at 68 months 58% (BCL-6 mutated, solid line) versus 44% (BCL-6 nonmutated, dotted line).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal